Secondary |
Metastases To Bone |
24.6% |
Anxiety |
9.5% |
Depression |
9.5% |
Non-small Cell Lung Cancer |
9.5% |
Schizophrenia |
9.5% |
Breast Cancer |
7.9% |
Plasmacytoma |
5.6% |
Carcinoid Tumour |
4.8% |
Myalgia |
3.2% |
Renal Transplant |
3.2% |
Blood Iron Increased |
1.6% |
Breast Cancer Metastatic |
1.6% |
Hypertension |
1.6% |
Multiple Myeloma |
1.6% |
Oral Lichen Planus |
1.6% |
Squamous Cell Carcinoma |
1.6% |
Bipolar Disorder |
0.8% |
Breast Cancer Female |
0.8% |
Chronic Myeloid Leukaemia |
0.8% |
Convulsion |
0.8% |
|
White Blood Cell Count Decreased |
25.0% |
Urinary Tract Infection |
11.4% |
Wound Drainage |
11.4% |
Tooth Extraction |
9.1% |
Inappropriate Antidiuretic Hormone Secretion |
6.8% |
Pneumonia |
4.5% |
Asthenia |
2.3% |
Convulsion |
2.3% |
Neoplasm Malignant |
2.3% |
Non-small Cell Lung Cancer |
2.3% |
Osteonecrosis |
2.3% |
Pain |
2.3% |
Pancytopenia |
2.3% |
Pulmonary Embolism |
2.3% |
Pulmonary Toxicity |
2.3% |
Sepsis |
2.3% |
Skin Disorder |
2.3% |
Skin Exfoliation |
2.3% |
Swelling |
2.3% |
Tachycardia |
2.3% |
|
Concomitant |
Breast Cancer |
18.9% |
Metastases To Bone |
14.2% |
Multiple Myeloma |
11.2% |
Breast Cancer Metastatic |
10.4% |
Prophylaxis |
9.9% |
Neoplasm Malignant |
5.5% |
Ovarian Cancer |
4.7% |
Renal Cell Carcinoma |
2.5% |
Discomfort |
2.4% |
Granulocyte Count Decreased |
2.4% |
Hot Flush |
2.4% |
Migraine |
2.4% |
Depression |
2.1% |
Sleep Disorder |
1.9% |
Premedication |
1.8% |
Prostate Cancer |
1.6% |
Prostate Cancer Metastatic |
1.6% |
Glucagonoma |
1.5% |
Pain |
1.4% |
Acromegaly |
1.2% |
|
Tooth Extraction |
20.0% |
Osteonecrosis |
14.8% |
Wound Treatment |
12.8% |
Weight Decreased |
10.0% |
White Blood Cell Count Decreased |
7.6% |
Pain In Jaw |
3.8% |
Toothache |
3.1% |
Vertebroplasty |
3.1% |
Wound Dehiscence |
3.1% |
Vocal Cord Disorder |
2.8% |
Wound Drainage |
2.8% |
Wound Debridement |
2.4% |
Dyspnoea |
2.1% |
Ulcer |
2.1% |
Wound Infection Staphylococcal |
2.1% |
Pyrexia |
1.7% |
Vomiting |
1.7% |
Sequestrectomy |
1.4% |
Swelling |
1.4% |
Tooth Disorder |
1.4% |
|
Interacting |
Acute Lymphocytic Leukaemia |
66.7% |
Sedative Therapy |
33.3% |
|
|